Accro Bioscience Advances Rare Disease Drug Development
Shanghai, China, September 11, 2026 Accro Bioscience has announced that its investigational AC-101 tablets have been included in the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Shanghai, China, September 11, 2026 Accro Bioscience has announced that its investigational AC-101 tablets have been included in the...
Berlin, Germany and New York, NY, September 12, 2026 Aignostics has launched PathoSearch, a new AI-powered visual search engine...
